[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5386 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 5386
To amend title XVIII of the Social Security Act to provide for
adjustments to the Medicare part D cost-sharing reductions for low-
income individuals.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 12, 2023
Mr. McGarvey (for himself and Mr. Bilirakis) introduced the following
bill; which was referred to the Committee on Energy and Commerce, and
in addition to the Committee on Ways and Means, for a period to be
subsequently determined by the Speaker, in each case for consideration
of such provisions as fall within the jurisdiction of the committee
concerned
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to provide for
adjustments to the Medicare part D cost-sharing reductions for low-
income individuals.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Cutting Copays Act''.
SEC. 2. ADJUSTMENTS TO MEDICARE PART D COST-SHARING REDUCTIONS FOR LOW-
INCOME INDIVIDUALS.
Section 1860D-14(a) of the Social Security Act (42 U.S.C. 1395w-
114(a)) is amended in paragraph (1)(D)(ii)--
(1) by striking ``that does not exceed $1 for'' and all
that follows through the period at the end and inserting ``that
does not exceed--
``(I) for plan years before plan
year 2024--
``(aa) for a generic drug
or a preferred drug that is a
multiple source drug (as
defined in section
1927(k)(7)(A)(i)), $1 or, if
less, the copayment amount
applicable to an individual
under clause (iii); and
``(bb) for any other drug,
$3 or, if less, the copayment
amount applicable to an
individual under clause (iii);
and''; and
(2) by adding at the end the following new subclauses:
``(II) for plan year 2024--
``(aa) for a generic drug,
$0; and
``(bb) for any other drug,
the dollar amount applied under
this clause (after application
of paragraph (4)(A)) for plan
year 2023 for a drug described
in subclause (I)(bb); and
``(III) for a subsequent year, the
dollar amount applied under this clause
for the previous year for the drug,
increased by the annual percentage
increase in the consumer price index
(all items; U.S. city average) as of
September of such previous year.''.
<all>